drugset / Trial / NCT00387946

Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)

NCT00387946 ↗

Phase 3 Completed 630 enrolled Sanofi
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary study objective is to demonstrate the efficacy of dianicline as an aid to smoking cessation in cigarette smokers. The main secondary objectives are to assess the: craving for cigarettes, nicotine withdrawal symptoms, and safety of dianicline.

Timeline

Start
2006-09
Primary completion
2007-09
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject dianicline Small molecule 40 mg —

Indications